Literature DB >> 23336366

'Targeting' sedation: the lived experience of the intensive care nurse.

Kirsty Everingham1, Tonks Fawcett, Tim Walsh.   

Abstract

AIMS AND
OBJECTIVES: To discuss the findings from a phenomenological study that provides insights into the intensive care nurses' 'world' following changes in the sedation management of patients in an intensive care unit.
BACKGROUND: Intensive care sedation practices have undergone significant changes. Patients, where possible, are now managed on lighter levels of sedation, often achieved through the performance of sedation holds (SHs). The performance of SHs is normally carried out by the bedside nurse but compliance is reported to be poor. There has been little exploration of the nurses' experiences of these changes and the implications of SHs and subsequent wakefulness on their delivery of care.
DESIGN: Following ethical approval, 16 intensive care nurses, experienced and inexperienced, from within a general intensive care unit.
METHODS: A Heideggerian phenomenological approach was used. Data collection consisted of interviews guided by an aide memoir and a framework adapted from Van Manen informed the analysis.
RESULTS: The findings reveal new insights into the world of the intensive care nurse in the light of the changes to sedation management. They demonstrate that there have been unforeseen outcomes from well-intentioned initiatives to improve the quality of patients' care. There were implications from the changes introduced for the nurses care delivery. The main themes that emerged were 'working priorities' and 'unintended consequences', in turn revealing embedded tensions between evidence-based targets and holistic care.
CONCLUSIONS: Intensive care nurses find that the current approach to the changes in sedation management can threaten their professional obligation and personal desire to provide holistic care. The 'targeted' approach by healthcare organisations is perceived to militate against the patient-centred care they want to deliver. RELEVANCE TO CLINICAL PRACTICE: Sedation management is complex and needs further consideration particularly the potential constraints 'target-led' care has on nursing practice.
© 2013 Blackwell Publishing Ltd.

Entities:  

Keywords:  Heideggerian phenomenology; healthcare targets; intensive care; nurses; patient safety; sedation

Mesh:

Substances:

Year:  2013        PMID: 23336366     DOI: 10.1111/jocn.12058

Source DB:  PubMed          Journal:  J Clin Nurs        ISSN: 0962-1067            Impact factor:   3.036


  5 in total

1.  Tolerance to sedative drugs in PICU: can it be moderated or is it immutable?

Authors:  Andrew R Wolf; Bronagh Blackwood; Brian Anderson
Journal:  Intensive Care Med       Date:  2015-11-24       Impact factor: 17.440

2.  Care erosion in sedation assessment: A prospective comparison of usual care Richmond Agitation-Sedation Scale assessment with protocolized assessment for medical intensive care unit patients.

Authors:  Christopher Charles Anderson; Jessica L Johnson; Bennett P deBoisblanc; Sarah E Jolley
Journal:  J Nurs Manag       Date:  2020-09-17       Impact factor: 3.325

3.  Missed nursing care and its influencing factors among neonatal intensive care unit nurses in South Korea: a descriptive study.

Authors:  Soohyun Kim; Sun-Mi Chae
Journal:  Child Health Nurs Res       Date:  2022-04-30

4.  Challenges and barriers to optimising sedation in intensive care: a qualitative study in eight Scottish intensive care units.

Authors:  Kalliopi Kydonaki; Janet Hanley; Guro Huby; Jean Antonelli; Timothy Simon Walsh
Journal:  BMJ Open       Date:  2019-05-24       Impact factor: 2.692

5.  Rationale, design and methodology of a trial evaluating three strategies designed to improve sedation quality in intensive care units (DESIST study).

Authors:  Timothy S Walsh; Kalliopi Kydonaki; Jean Antonelli; Jacqueline Stephen; Robert J Lee; Kirsty Everingham; Janet Hanley; Kimmo Uutelo; Petra Peltola; Christopher J Weir
Journal:  BMJ Open       Date:  2016-03-04       Impact factor: 2.692

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.